We studied prospectively the effects of 2% hydroxypropylmethylcellulose (HPMC), instilled in to the anterior chamber during extracapsular cataract extraction with posterior chamber intraocular lens implantation in 122 patients. Significant pres sure rise was noted at 12 and 24 hours post-operatively when HPMC was not removed at the end of surgery. This was prevented by washing HPMC from the anterior chamber at the end of surgery, or by using either acetazolamide or a combi nation of oxyphenbutazone and vitamin C without washing HPMC. There was no difference in intraocular inflammation between controls and the HPMC groups. The group receiving acetazolamide without washing HPMC had the most inflammation, while the group receiving combined oxyphenbutazone and vitamin C had the least, the differences between these two groups being sufficient.
Visco-elastic substances offer a number of advantages to the ophthalmic surgeon, such as gentle creation or maintenance of surgical spaces, tissue planes, and protection of tis sues.l Three visco-elastic substances are currently in use: sodium hyaluronate (SH), hydroxypropylmet h yl-cellulose (HPMC) , and chondroitin sulphate (CS).
Fleming and co-workers in 1959 showed that 0.5% HPMC did not cause significant in flammation in rabbit eyes and was undetect able after three days, suggesting it exited through the normal ocular out flow pathways. 2 Robert and co-workers3 injected 2% HPMC into rabbit anterior chambers and observed corneal oedema and anterior cham ber fibrin during the first week. Histopath- ologic studies of the eyes at 3, 6, 13 and 25 days were normal. SH 1%, HPMC2% and CS 3-4% protected cat corneal endothelium equally from mech anical trauma.4 Intraocular in flammation increased mildly in all of the cats' eyes. High intraocular pressures, first appearing after four hours and lasting 8-24 hours, were reduced by anterior chamber washout of the four preparations.
HPMC 0.4% mildly protected rabbit endo thelium.5 Pressure rose much less than SH or .10-20% CS (viscosity 0.4%< 2% HPMC, 40 vs 40 00 cp). Pressure peaks at one to four hours when tested the following day were missed and pressures returned to normal affer 14 hours.
HPMC 2% protected cat and monkey Liesegang and co-workers1o compared 2% HPMC and 1% SH in ECCE /PCIOL patients. Neither group showed excessive in flammation/toxicity, central endothelial cell loss being equal in the two groups. Intraocular pressure, not measured in the initial post operative hour-s, was normal after three days.
Bigar and co-workersll studied 2% HPMC in 65 patients. Intraocular pressure, not measured in the initial postoperative hours, was occasionally elevated one day post-oper atively, and was normal the second pos t operative day. No differences from controls were found (epithelial oedema, thickness, Descemet's folds, anterior chamber, pupil, iris, vitreous, fundus).
Fechner and Rimpler12 found no significant differences in anterior chamber in flammatory reaction between SH and 2% HPMC in 100 ECCE/PCIOL patients.
Thomsen and co-workers13 found no differ ences in anterior chamber in flammation or intraocular pressure between SH and 2% HPMC in 30 ECCE /PCIOL patients. Day of surgery pressure was not measured. All 15 HPMC patients had reduced pressure begin ning by the first postoperative day.
HPMC is the least expensive of the three visco-elastic substances. Judgement of cost; benefit: risk is an important surgical responsi. bility. We report a study designed to evalua te prospectively 2% HPMC in ECCEIPCIOL patients, including a set of day of surgery observations. 
Materials and Methods
All patients included in the study underwent routine extracapsular cataract extraction, fol lowed by insertion of a Sinsky-style posterior chamber intraocular lens. Two per cent HPMC was prepared accord ing to the method of Fechner .14 With use of a syringe, we performed positive pressure fil tration of the solution through a 1.21-1 poly flu orotetraethylene (P T FE) membrane filter (Sartorius Co rp).
Patients were allocated to one of the fol lowing groups: (1) Co ntrol group, HPMCwas not used, only balanced salt solution employed. (2) HPMC used but completely removed at end of operation. (3) HPMC used but not removed. (4) HPMC used but not removed, acetazola mide 250 mg given by mouth every six hours for 36 hours post-operatively. (5) HPMC used but not removed, oxyphen butazone 50 mg given by mouth every six hours for 72 hours post-operatively. (6) As for group five but also with use of vitamin C 500 mg given by mouth 30 minutes pre-operatively, and then every six hours post-operatively for 72 hours. A detailed proforma was completed for every patient, three sets of observations were recorded at the following times: 12 hours pre operatively; and 12, 24, 48 and 72 hours post operatively. The three sets of observations were: intraocular pressure (Goldmann tonometry), anterior chamber cellular reac tion, and anterior chamber flare (both the latter defined according to currently accepted criteria.15 The treatment group was known neither to the patient nor the observer.
Results
There were 122 patients in the study (59 males, 63 females). Breakdown by treatment groups was: Group 1, 36 patients; Group 2, 28; Group 3, 16; Group 4, 21; Group 5, 8; Group 6, 13 patients.
The results of serial measurements of intra ocular pressure, anterior chamber cellular reaction, and anterior chamber flare are shown in Figures 1, 2 and 3 , respectively. Sig- nificant differences in intraocular pressure were found between Groups 3 and 5 on the one hand and Groups 1, 2, 4 and 6 on the other hand, at 12 and at 24 hours after surgery. Significant differences in both anterior cham ber cells and flare were found between Group 4 and Group 6 at 72 hours after surgery.
Discussion
In this prospective study we analysed the effects of instillation of a 2% solution of HPMC into the anterior chamber during extracapsular cataract surgery, followed by insertion of a posterior chamber intraocular lens. HPMC was very easy to use. Satisfactory maintenance of the anterior chamber by HPMC was observed in all cases, which made insertion of a posterior chamber intraocular lens easier. A rise in intraocular pressure was observed at 12 and 24 hours post-operatively, in Group 3 in which HPMC was used but not removed, and in Group 5 in which HPMC was used together with use of oxyphenbutazone alone in the post-operative period (Fig. 1) . How ever, the degree of rise in intraocular pressure was not different between these two groups.
The rise in post-operative intraocular pres sure observed in Groups 3 and 5 differed sig nificantly from the remaining four treatment groups (Fig. 1) , in whom no such rise was observed and among whom no significant inter-group differences were found. It would therefore appear that the observed rise in intraocular pressure at 12 and 24 hours post operatively may be prevented equally well by either washing HPMC from the anterior chamber at the end of surgery, or by not removing it but using either acetazolamide 250 mg every six hours post-operatively, or as combination of oxyphenbutazone 50 mg every eight hours and vitamin C 500 mg (once 30 minutes pre-operatively, then every six hours) in the post-operative period. These results raise the question of whether vitamin C alone would exert the same preventive action.
There were no significant differences observed between the control Group 1 and the HPMC treatment groups 2-5 as regards the appearance of cells and flare in the anterior chamber (Figs. 2 and 3 ). HPMC 2% does not appear therefore to be toxic to the anterior chamber structures. Group 4 receiv ing acetazolamide wit hout was hing HPMC had the most in flammation, while Group 6 receiving combined oxyp henbutazone and vitamin C had the least, the differences between these two last groups being signifi cant (Figs. 2 and 3) . Fec hner!6 found elevated intraocular pres sure in 63 patients after ECCE and iris claw (not posterior chamber) lens implantation with use of 2% HPMC (mean lOP morning of first post-operative day 36.8) but not in 26 patients receiving a secondary iris claw lens implantation also using 2% HPMC (mean lOP morning of first post-operative day 21.6). He attributed the rise in the first group to the primary surgery and not to HPMC, since bot h groups received 2% HPMC and the same 10L type but differed only in the type of operative procedure performed. His findings could also be interpreted as a temporary overload of the out flow structures by HPMC plus lens matter/ in flammatory products compared to just HPMC.
Rosen and co-workers!? found impurities and particulate matter in six samples of 2% HPMC from European pharmacies. They questioned its safety for intraocular use; they compared the six samples wit h a commercial sample of met hylcellulose eye drops specific ally not recommended for intraocular use and incubated the materials wit h chloramp hen icol, et hanol, and beta-glucosidase enzyme solution. Overnig ht incubation of this mixture produced gross particulate precipitated material present to an equal degree in the unfiltered eye drops not intended for intra ocular use and the allegedly filtered solutions whose labels indicated that they were for intraocular use. Many obvious glass frag ments present in the samples indicated that the containers had not been adequately cleaned.
Fec hner and Rimpler!2 tested 2% HPMC solutions made by a hospital pharmacy and an industrially prepared solution. They exam ined samples wit hdrawn from the bottom of test tubes containing ultracentrifuged HPMC and found no particles or sediments or fibres wit h use of lig ht or interference phase contrast microscopy. Gram and MGG staining of the samples was negative. Amino acid analysis showed no proteins or amino acids of botani cal origin. On the ot her hand, they found that even a single filter paper fibre artefactually added to the solutions was easily demon strable by their tec hniques. Suc h artefactually added filter paper fibres resulted in fibre clus ters resembling those shown by Rosen and co workers.!? They suggested that the solutions examined by Rosen and co-workers had, among ot her things, not been properly filtered.
Tec hnical details of preparation. are extremely important. Details regarding use of hig hest quality reagent grades of HPMC are provided by Fec hner!4 and should be fol lowed. HPMC reagent powder routinely available on the market is not of this quality. Met hylcellulose eye drops not intended for intraocular use contain in addition endot he lium-toxic preservatives and are of course absolutely contraindicated for intraocular use. In no way should filter paper be used for filtration. We injected 2% HPMC solution throug h 1.2 11 poly fluorotetraet hylene (P TFE) membrane filters (Sartorius Co rp) wit h a syringe using positive pressure, thereby eliminating the step of negative suction whic h Rosen!? suggested may have introduced the particulate matter whic h he observed in the specimens he examined. We examined the solutions we prepared and found them to be completely clear and free of microscopic particles.
Properly prepared 2% HPMC gives excel lent results, but not if the necessary expertise and supervision are lacking. This material is available from industrial sources in several countries (for example Adatomed Co ., West Germany; Barnes-Hind Co ., USA; Dispersa Co ., Switzerland; Faure Laboratories, France; Storz Co ., USA).
HPMC is less expensive than other visco elastic substances currently available. It has proven very simple to use in our experience. A rise in intraocular pressure occurring at 12 and 24 hours post-operatively may be preven ted by was hing HPMC from the eye at the end of surgery, or by leaving HPMC in the eye and using either acetazolamide or a combination of oxyphenbutazone and vitamin C in the post-operative period. Because of the design of our study, we are unable to comment on the pressure status sooner than 12 hours post operatively. Our results suggests that this should be looked at in future studies.
A 2% HPMC solution.is water soluble and easy to wash out at the conclusion of surgery. on the other hand, there are times (for example, a restless patient, positive vitreous pressure, a complicated procedure, a repeat edly collapsing anterior chamber which has just been satisfactorily reformed, or an already surgically closed wound) when it is safer or more judicious to make no further surgical manoeuvres within the eye. Reten tion of HPMC and medical prevention of pressure rise as described above would offer a safe alternative to HPMC removal. Acetazo lamide or combined oxyphenbutazone/vita min C accomplish this equally well, but use of combined oxyphenbutazone/v itamin C results in significantly less in flammation than use of acetazolamide. Perhaps one should use the above mentioned medical treatment pro phylactically anyway in cases where HPMC is removed at the end of the procedure but con siderable lens matter remains in the eye, or in cases of chronic glaucoma (for whom post operative pressure rises are known to occur with other viscoelastic substances despite their removal)18 or in which optic nerve dam age is already evident or suspected before sur gery. According to the results of our study, 2% HPMC does not appear to have any toxic effects upon the structures of the anterior chamber.
